Simplifying the dosimetry of carbon-11-labeled radiopharmaceuticals

Journal of Nuclear Medicine

Volumn 38, Issue 4, 1997, Pages 654-660

  Wrobel, Mark C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

carbon 11; dosimetry; PET

Indexed keywords

CARBON 11;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; CALCULATION; COMPARTMENT MODEL; DATA ANALYSIS; DOSIMETRY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; RAT;

ANIMALS; CARBON RADIOISOTOPES; GALLBLADDER; RADIATION DOSAGE; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; URINARY BLADDER;

EID: 0030950121     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. International Commission on Radiation Units. Measurements. Methods of assessment oj absorbed dose in clinical use ofradionuclides. ICRU Report 32. London: Pergamon Press: 1979.
2. Mullholland GK, Otto C'A. Jcwett DM, et al. Synthesis, rodent biodistribution, dosimctry, metabolism and monkey images of "C-labeled ( + )-2a-tropanyl benzilate: a central musearinic receptor imaging agent. J Nucl Med I992;33:423- 430.
3. Wong DF, Bice AN. Beck T, Dannals RF. Links JM. Wagner HN. Considerations for dosimetry calculations with ncuroreceptor binding radioligands. Fourth international radiopharmaccutical dosimetry symposium. Oak Ridge Associated Universities. CONF-8511 13-(DF86010102); 1985:245-259.
4. Galley JS. Estimation of upper limits on human radiation absorbed doses from "C-labeled compounds. J Nucl Med 1993:34:2208-2215.
5. Schaumann W, Neubert P. Animal experiments for estimating the radiation exposure of human subjects by radioactive drugs. Pharmacology' 1988:37:333-340.
6. International Commission on Radiological Protection. Radiation dose to patients from radiopharmaceuticals. Oxford: Pergamon Press; ICRP Report; 1988:53.
7. Cloutier R.I, Smith SA, Watson EE, Snyder WS. Warner GG. Dose to the fetus from radionuclides in the bladder. Health Physics 1973:25:147 161.
8. Syed IB. Dosimetry of ' n'"I radiopharmaceuticals with special attention to the urinary bladder. Radiopharmaceutical dosimetry symposium. HEW Publication (FDA 76 8044). Rockville. MD: Department of Health Education and Welfare. Bureau of Radiological Health; 1976:306-369.
9. MIRD. Medical Internal Radiation Dose Committee Estimate Report No. 7. Summary of current radiation dose estimates to humans from I21I, 124I, I2M. I2"I. ' l"l and ml as sodium rose bengal. ,/ Nucl Med 1975:16:1214-1217.
10. Koutoulidis C. Chiotellis E, Eymberis C. Absorbed dose estimation of some TC- hepatobiliary agents. Ear J Nucl Med I979;4:441 -444.
11. Brown PI I. K-rishnamurthy GT. Bobby VR, Kingston E. Radiation-dose calculation for -HIDA in health and disease. J Nucl Med 1981;22:I77-183.
12. Brown PH. Krishnamurthy GT. Bobby VR. Kingston L. Turner FE. Radiation dose calculation for five Wn'Tc-IDA hepatobiliary agents. J Nucl Med 1982;23:1025- 1030.
13. Snyder WS. Ford MR. Estimation of doses to the urinary bladder and to the gonads. Radiophurrtuiceutical dosimelrv svmposium, HEW Publication ( FDA 76 - 8044). Rockville, MD: Department of Health. Education and Welfare. Bureau of Radiological Health; 1976:313 349.
14. Smith T. Veall. Wootton R. Bladder wall dose from administered radiopharmaceuticals: the effect of variation in urine How rate, voiding interval and initial bladder content. Radial Prot Dosim 1982:2:183 189.
15. Wagner HN. Smith EM, Brownell GL, Elicit WH. Principles of nuclear medicine, radiation dosimetrv. Philadelphia: Saunders; 1968:742-784.
16. Roedlcr HD. Accuracy of internal dose calculations with special consideration of radiopharmaceuticals biokinctics. Third international radiopharmaceutical dosimetry symposium. Oak Ridge National Laboratory. IlllS-Publication (FDA);I980:I-20.
17. Stabin MGMIRDOSE. Personal computer software for internal dose assessment in nuclear medicine. ./ AW Med 1996:37:538 546.
18. Coffey JL, Watson F. Calculating dose from remaining body activity: a comparison of two methods. Med Phvs 1979:6:307 308.
19. Loevinger R. Bennan M. MIRD pamphlet no. I, revised. A revised scheme for calculating ahsorhed dose from biologically distributed radionuclides. New York: Society of Nuclear Medicine; 1976.
20. Berman M. MIRD pamphlet no. 12: kinetics models (or absorbed dose calculations. New York: Society of Nuclear Medicine;1977.
21. McAfee JG. Subramanian G. Interpretation of interspecies differences in the biodistribution of radiative agents. Third international radiopharmaceutical dosimetry symposium. Oak Ridge National Laboratory, HHS-Publication (PDA); 1980:292-306.
22. International Commission on Radiological Protection. Radiological protection in biomédical research. Oxford: Pergamon Press; 1CRP Report 62; 1993.
23. International Commission on Radiological Protection. Recommendation of the Inter-national Commission on Radiological Protection. Oxford: Pergamon Press; ICRP Report 1991:60.
24. Food and Drag Administration. Part 361: prescription drugs for human use generally recognized as safe and effective and not mishranded: drugs used in research. Fec! Reg 1990:21:200-205.
25. Cherry SR. Dahlhom M. Hoffman EJ. Three-dimensional PF.T using a conventional multislice tomograph without septa. J Compul Assist Tomogr 1991:15:655-668.